Alta Advisers’s SOPHiA GENETICS SOPH Stock Holding History

Alta Advisers’s Portfolio SOPH Stock Details SOPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,000	Closed	-$110K	–	383
2022 Q3	$110K	Buy	+1,000	New	+$3.5K	0.07%	182

Other funds holding SOPH

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

BPC

Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

AWA

Alta Wealth Advisors Woburn, Massachusetts $308M AUM 27.87% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

General Electric Evendale, Ohio $369M AUM 19.65% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Alta Advisers's SOPH Position: Q4 2022 in Review

Alta Advisers sold out of SOPHiA GENETICS (SOPH) in Q4 2022, closing a stake of 1,000 shares — an estimated $110K sold.

Alta Advisers first reported a position in SOPH in Q3 2022 and held it in 1 quarter. The position peaked at $110K in Q3 2022. 32 funds tracked by Wall St. Rank hold SOPH as of Q4 2022.

Alta Advisers reported no remaining SOPHiA GENETICS position as of Q4 2022 after selling out during the quarter.
Alta Advisers sold 1,000 SOPHiA GENETICS shares in Q4 2022, an estimated $110K.
Alta Advisers first reported a position in SOPHiA GENETICS in Q3 2022 and held it in 1 quarter.
Alta Advisers's SOPHiA GENETICS position peaked at $110K in Q3 2022.
32 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q4 2022.

Based on Alta Advisers's 13F filing for Q4 2022, filed 27 Jan 2023.